Article Text

Download PDFPDF

Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography.
  1. K L Leenders,
  2. A J Palmer,
  3. N Quinn,
  4. J C Clark,
  5. G Firnau,
  6. E S Garnett,
  7. C Nahmias,
  8. T Jones,
  9. C D Marsden


    L-[18F] fluorodopa was administered in trace amounts intravenously to healthy control subjects and to patients with Parkinson's disease. Striatal uptake of radioactivity was measured using positron emission tomography. The capacity of the striatum to retain tracer was severely impaired in patients compared to controls. This may reflect a reduction of striatal dopamine storage in Parkinson's disease. Patients showing the "on/off" phenomenon had an even greater decrease of striatal storage capacity.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.